Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Luxturna concentrate and solvent for solution for injection {equilateral_black_triangle}

Active Ingredient:
voretigene neparvovec
Company:  
Novartis Pharmaceuticals UK Ltd See contact details
ATC code: 
S01XA27
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials Audio/Video Live Chat HCP Med Info
{arrow_left}
{arrow_right}
Audio Guides to Luxturna - Click on the PLAY button to listen, or right click to save the audio file. To view or download text versions see the 'Patient Leaflet' and 'Risk Materials' tabs.
Luxturna (voretigene neparvovec) Patient Information Leaflet - Audio Version
Patient information leaflet voiceover detailing all the information a patient needs to know about taking or using their medicine


Luxturna (voretigene neparvovec) Patient Alert Card - Audio Version
Patient card to track treatment and provide useful contact details


Novartis Pharmaceuticals UK Ltd
Company image
Address
2nd Floor, The WestWorks Building, White City Place, 195 Wood Lane, London, W12 7FQ
Telephone
+44 (0)1276 692 255
E-mail
[email protected]
Medical Information Direct Line
+44 (0)1276 698 370
Medical Information e-mail
[email protected]
Customer Care direct line
+44 (0)845 741 9442